Literature DB >> 11303655

Significance of CSF area measurements in cervical spondylitic myelopathy.

A Golash1, D Birchall, R D Laitt, A Jackson.   

Abstract

Mild clinical myelopathy can occur without cord compression, and asymptomatic cord compression seen on MRI is common. The aim of this study was to ascertain the MRI features which best correlate with early clinical myelopathy. The study was conducted on three groups: group A, 20 patients with clinical myelopathy and MRI evidence of cervical spondylosis; group B, 20 patients without myelopathy, but with other clinical and MRI evidence of cervical spondylosis; and group C, 10 normal volunteers with no MRI evidence of spondylosis. The cross-sectional area (CSA) of the spinal cord (SP-CSA), spinal canal (SC-CSA) and CSF space (CSF-CSA) were measured on T1-weighted axial images at the level of the most severe spinal canal stenosis. The severity of myelopathy was assessed using a simple scoring system giving a score from 0 (normal) to 11 (severe). Subjective demonstration of cord compression on sagittal images was an insensitive indicator of clinical myelopathy. All three measures of cross-sectional area were significantly smaller in Group A than in B (p<0.01). The reduction in SP-CSA was the only independent prognosticator for severity of myelopathy (p<0.005) accounting for 63% of the variation in myelopathy score. All three variables showed a significant correlation with the presence of myelopathy (p<0.01); however, logistic regression analysis showed a decrease in CSF-CSA to be the only independent significant prognosticator of the presence of clinical myelopathy (p<0.02). Reduction of the CSF space to less than 0.7 cm2 was associated with a 90% chance of clinical myelopathy (specificity 83%).

Entities:  

Mesh:

Year:  2001        PMID: 11303655     DOI: 10.1080/02688690020024337

Source DB:  PubMed          Journal:  Br J Neurosurg        ISSN: 0268-8697            Impact factor:   1.596


  6 in total

1.  MRI of the cervical spine with neck extension: is it useful?

Authors:  R J V Bartlett; C A Rowland Hill; A S Rigby; S Chandrasekaran; H Narayanamurthy
Journal:  Br J Radiol       Date:  2012-01-03       Impact factor: 3.039

Review 2.  Risk factors for development of myelopathy in patients with cervical spondylotic cord compression.

Authors:  Shunji Matsunaga; Setsuro Komiya; Yoshiaki Toyama
Journal:  Eur Spine J       Date:  2013-05-23       Impact factor: 3.134

3.  Measurement of volume-occupying rate of cervical spinal canal and its role in cervical spondylotic myelopathy.

Authors:  Fulong Dong; Cailiang Shen; Shu Jiang; Renjie Zhang; Peiwen Song; Yongqiang Yu; Shiyu Wang; Xiaohu Li; Gang Zhao; Changhai Ding
Journal:  Eur Spine J       Date:  2013-01-06       Impact factor: 3.134

4.  Presymptomatic spondylotic cervical myelopathy: an updated predictive model.

Authors:  Josef Bednarik; Zdenek Kadanka; Ladislav Dusek; Milos Kerkovsky; Stanislav Vohanka; Oldrich Novotny; Igor Urbanek; Dagmar Kratochvilova
Journal:  Eur Spine J       Date:  2008-01-12       Impact factor: 3.134

5.  Correlation of magnetic resonance imaging findings and reported symptoms in patients with chronic cervical dysfunction.

Authors:  Rogelio Coronado; Beverly Hudson; Charles Sheets; Matthew Roman; Robert Isaacs; Jessie Mathers; Chad Cook
Journal:  J Man Manip Ther       Date:  2009

6.  Risk factors for development of cervical spondylotic myelopathy: results of a systematic review.

Authors:  Anoushka Singh; Lindsay Tetreault; Michael G Fehlings; Dena J Fischer; Andrea C Skelly
Journal:  Evid Based Spine Care J       Date:  2012-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.